TDOC - NYSE

Teladoc Health, Inc.

TDOC·NYSE

$7.36

-2.5%

HealthcareMedical - Healthcare Information Services

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.33B

EPS-1.1400

P/E Ratio-6.45

Earnings Date07/29/2026

3.10B

Assets

-12%

3Y-34.0%

5Y-83.0%

10Y+921.0%

1.72B

Total Liabilities

-15%

3Y-28.0%

5Y-8.0%

10Y+2256.0%

1.39B

Total Equity

-7%

3Y-40.0%

5Y-91.0%

10Y+500.0%

Teladoc Health, Inc. Funding & Solvency Profile

TDOC · NYSE

Current Assets

Cash & Cash Equivalents781.08M

Net Receivables201.66M

Inventory38.20M

Other Current Assets2.07M

Total Current Assets1 B

Non-Current Assets

Property, Plant & Equipment53.09M

Goodwill & Intangible Assets1.58B

Long-Term Investments0.00

Other Non-Current Assets137.62M

Total Non-Current Assets191 M

Total Assets

3.10B

Financial Health Analysis

Current Ratio

2.69x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

1.24x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

683 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

35% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Teladoc Health, Inc. Balance Sheet

TDOC • NYSE

Teladoc Health, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	781.1M	1.3B	1.1B	918.2M	893.5M	733.3M	514.4M	424M	42.8M	50M	55.1M	46.4M	3.2M
Short-Term Investments	0.0	0.0	0.0	0.0	2.5M	53.2M	2.7M	54.5M	79.5M	15.8M	82.3M	0.0	0.0
Cash & Short-Term Investments	781.1M	1.3B	1.1B	918.2M	896M	786.6M	517.1M	478.5M	122.3M	65.8M	137.3M	46.4M	3.2M
Net Receivables	201.7M	224M	230.1M	235.6M	190.1M	169.3M	56.9M	43.6M	27.1M	13.8M	12.1M	7.1M	2.9M
Accounts Receivables	192.8M	214.1M	217.4M	210.6M	169M	169.3M	56.9M	43.6M	27.1M	13.8M	12.1M	6.8M	2.6M
Other Receivables	8.8M	9.8M	12.6M	25.1M	21.2M	0.0	0.0	0.0	0.0	0.0	0.0	253K	253K
Inventory	38.2M	38.1M	29.5M	56.3M	73.1M	56.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Prepaids	64.3M	67.5M	65.7M	63.2M	38.3M	47.3M	0.0	10.6M	6.8M	3.1M	2.1M	966K	743K
Other Current Assets	2.1M	36M	40.1M	12.1M	28M	0.0	14M	10.6M	6.8M	0.0	2.1M	0.0	8K
Total Current Assets	1.1B	1.7B	1.5B	1.3B	1.2B	1.1B	588M	532.7M	156.2M	82.7M	151.6M	54.7M	6.8M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	53.1M	56.6M	72.1M	71.5M	74M	75.2M	36.7M	10.1M	9M	7.5M	6.3M	1.1M	331K
Goodwill	283.2M	283.2M	1.1B	1.1B	14.5B	14.6B	746.1M	737.2M	498.5M	188.2M	56.3M	28.5M	14.8M
Intangible Assets	1.3B	1.4B	1.7B	1.8B	1.9B	2B	225.5M	247.4M	159.8M	24.9M	15.3M	7.5M	5.4M
Goodwill & Intangible Assets	1.6B	1.7B	2.8B	2.9B	16.4B	16.6B	971.5M	984.6M	658.3M	213.1M	71.6M	36M	20.1M
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	-69.6M	94M	49.4M	0.0	0.0	0.0	0.0
Tax Assets	242.5M	0.0	0.0	355.6M	0.0	0.0	69.6M	-94M	-49.4M	0.0	0.0	0.0	0.0
Other Non-Current Assets	137.6M	81.5M	80.3M	78.5M	20.7M	18.4M	6.5M	1.4M	858K	415K	293K	296K	93K
Total Non-Current Assets	2B	1.9B	2.9B	3.4B	16.5B	16.7B	1B	996.1M	668.2M	221M	78.2M	37.3M	20.6M
Total Assets	3.1B	3.5B	4.4B	4.7B	17.7B	17.8B	1.6B	1.5B	824.4M	303.7M	229.7M	92M	27.4M
LIABILITIES
CURRENT LIABILITIES
Total Payables	48M	33.1M	44.3M	51.5M	60.3M	49.8M	9.1M	10.4M	3.9M	2.2M	2.2M	2.2M	67K
Accounts Payable	48M	33.1M	43.6M	47.7M	47.3M	46M	9.1M	7.8M	3.9M	2.2M	2.2M	2.2M	67K
Other Payables	0.0	0.0	621K	3.8M	13.1M	3.7M	0.0	2.6M	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	96.3M	198.7M	102.7M	81.6M	50.2M	47.6M	52.3M	27.9M	24.4M	9.9M	9M	3.4M	1.8M
Short Term Debt	11M	550.7M	0.0	13.6M	0.0	42.6M	0.0	0.0	0.0	2M	1.3M	833K	0.0
Capital Lease Obligations (Current)	0.0	10.3M	10.8M	0.0	12.7M	11.4M	5.1M	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	28.1M	13.6M	3.8M	13.1M	3.7M	2.9M	2.6M	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	62.3M	79.3M	95.7M	101.8M	75.6M	52.4M	12.5M	7.7M	4.1M	1M	831K	5.4M	0.0
Other Current Liabilities	187.2M	69.3M	167.3M	151.3M	132.2M	128.9M	23.7M	16.5M	12.1M	5.9M	5.5M	6.6M	3.3M
Total Current Liabilities	404.7M	941.5M	420.6M	399.8M	331M	332.6M	90.2M	62.4M	40.3M	21.1M	18M	13M	5.1M
NON-CURRENT LIABILITIES
Long Term Debt	994.9M	991.4M	1.5B	1.5B	1.2B	1.4B	440.4M	414.7M	207.4M	42.4M	25.2M	25.2M	3M
Deferred Revenue (Non-Current)	9.1M	9.8M	13.6M	12M	3.8M	2.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	271.4M	49.9M	49.5M	406.5M	75.8M	102.1M	21.7M	32.4M	12.9M	1.7M	1.2M	494K	102K
Other Non-Current Liabilities	643K	720K	1.1M	1.6M	10.8M	11.5M	33.2M	6.2M	17.8M	7.6M	6.8M	62K	88K
Total Non-Current Liabilities	1.3B	1.1B	1.6B	2B	1.4B	1.5B	498.6M	453.3M	225.2M	51.7M	33.2M	25.8M	3.2M
Capital Lease Obligations	34.2M	42.5M	53.6M	38M	54.5M	54.6M	25M	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	1.7B	2B	2.1B	2.4B	1.7B	1.9B	588.8M	515.8M	265.5M	72.8M	51.2M	38.8M	8.3M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	229.7M	117.9M	71.7M
Common Stock	178K	173K	167K	163K	160K	150K	73K	70K	61K	46K	38K	27K	2.9M
Additional Paid-In Capital	17.9B	17.8B	17.6B	17.4B	17.5B	16.9B	1.5B	1.4B	866.3M	435.6M	309.1M	5M	0.0
Retained Earnings	-16.4B	-16.2B	-15.2B	-15B	-1.4B	-992.7M	-507.5M	-408.7M	-311.6M	-204.7M	-130.5M	-72.5M	-55.5M
Accumulated Other Comprehensive Income/Loss	-34.7M	-38.4M	-37M	-42.8M	-6.3M	18.5M	-17.2M	-13.1M	4.1M	-1K	-42K	-1.3M	-927K
Total Stockholders' Equity	1.4B	1.5B	2.3B	2.3B	16B	15.9B	1B	1B	558.9M	230.9M	178.6M	53.2M	19.1M
Total Equity	1.4B	1.5B	2.3B	2.3B	16B	15.9B	1B	1B	558.9M	230.9M	178.6M	53.2M	19.1M
SUMMARY
Total Liabilities & Equity	3.1B	3.5B	4.4B	4.7B	17.7B	17.8B	1.6B	1.5B	824.4M	303.7M	229.7M	92M	27.4M
Total Investments	0.0	0.0	0.0	0.0	2.5M	53.2M	-66.8M	54.5M	79.5M	15.8M	82.3M	0.0	0.0
Total Debt	1B	1.6B	1.6B	1.6B	1.3B	1.5B	465.4M	414.7M	207.4M	44.4M	26.5M	26M	3M
Net Debt	259.1M	286.3M	468.6M	668.7M	386.7M	743.4M	-48.9M	-9.3M	164.6M	-5.6M	-28.6M	-20.4M	-212K
Shares Outstanding	177,473,000	177,473,000	177,473,000	177,473,000	177,473,000	177,473,000	177,473,000	177,473,000	177,473,000	177,473,000	177,473,000	177,473,000	177,473,000

SEC Filings

TDOC - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 21, 2026	May 21, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 30, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 29, 2026	April 29, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 07, 2026	May 21, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 30, 2026	March 30, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 25, 2026	February 25, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 18, 2026	February 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 12, 2026	February 08, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 16, 2025	December 11, 2025	2025	View Filing

Showing 1 to 10 of 207 filings

Related Guides

Blog Categories

Continue your TDOC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.